Insider Transactions in Q4 2022 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,000
-8.37%
|
$56,000
$7.01 P/Share
|
|
Dec 06
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
4,792
-3.84%
|
$47,920
$10.61 P/Share
|
|
Dec 06
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.66%
|
$22,500
$3.12 P/Share
|
|
Dec 06
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
48,250
-3.32%
|
$482,500
$10.61 P/Share
|
|
Dec 06
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,365
+4.92%
|
$226,095
$3.12 P/Share
|
|
Dec 05
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
47,650
-3.34%
|
$476,500
$10.62 P/Share
|
|
Dec 05
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
74,635
+4.97%
|
$223,905
$3.12 P/Share
|